🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

30,79 USD

Máx. histórico

61,25

1784 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-49,73%

Rango 52 semanas

23,62 – 31,06

Variación hoy

+2,63%

Cierre anterior

30,00

Rango de hoy

30,04 – 30,90

Volumen hoy

48.251.619

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,33%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
41,61 (puede no estar actualizado)
Dividend yield
5,73% (puede no estar actualizado)
Precio objetivo analistas
29,45 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 21 horas
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 5,59%
Fecha de pago Importe por participación
24/07/2026 0,4300 USD
08/05/2026 0,4300 USD
23/01/2026 0,4300 USD
07/11/2025 0,4300 USD
25/07/2025 0,4300 USD
09/05/2025 0,4300 USD
24/01/2025 0,4300 USD
08/11/2024 0,4200 USD
26/07/2024 0,4200 USD
09/05/2024 0,4200 USD
25/01/2024 0,4200 USD
09/11/2023 0,4100 USD
27/07/2023 0,4100 USD
11/05/2023 0,4100 USD
26/01/2023 0,4100 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/05/1997 16,05 16,15 15,77 15,85 -0,62% 2,34% 6.725.574
20/05/1997 15,79 16,01 15,69 15,95 +0,50% 2,00% 6.044.479
19/05/1997 15,91 16,01 15,81 15,87 -0,37% 1,24% 5.711.204
16/05/1997 16,21 16,21 15,79 15,93 -1,71% 2,56% 8.187.050
15/05/1997 15,97 16,21 15,89 16,21 +1,49% 1,98% 4.236.448
14/05/1997 16,03 16,13 15,87 15,97 +0,62% 1,60% 5.657.450
13/05/1997 16,11 16,19 15,73 15,87 -0,86% 2,82% 7.961.284
12/05/1997 15,58 16,11 15,57 16,01 +3,32% 3,49% 7.172.681
09/05/1997 15,48 15,63 15,14 15,50 +0,90% 3,19% 7.277.027
08/05/1997 15,28 15,62 15,22 15,36 +0,13% 2,59% 8.909.884
07/05/1997 15,67 15,75 15,34 15,34 -2,27% 2,65% 5.902.189
06/05/1997 15,75 15,87 15,58 15,69 -0,50% 1,88% 9.145.769
05/05/1997 15,46 15,97 15,36 15,77 +2,44% 3,96% 10.831.115
02/05/1997 15,18 15,42 15,16 15,40 +1,30% 1,69% 9.752.873
01/05/1997 15,18 15,30 15,02 15,20 +0,13% 1,82% 7.297.896
30/04/1997 15,28 15,40 15,12 15,18 -1,41% 1,81% 10.273.338
29/04/1997 15,06 15,50 14,96 15,40 +3,32% 3,54% 8.648.702
28/04/1997 14,65 15,04 14,61 14,90 +1,75% 2,97% 9.873.661
25/04/1997 14,71 14,73 14,59 14,65 -0,80% 0,94% 6.721.147
24/04/1997 14,73 14,84 14,41 14,77 +0,81% 2,95% 10.340.372
23/04/1997 14,57 14,73 14,53 14,65 +0,95% 1,36% 7.447.775
22/04/1997 14,27 14,55 14,19 14,51 +3,23% 2,49% 14.622.353
21/04/1997 13,95 14,29 13,90 14,05 +0,71% 2,83% 9.093.912
18/04/1997 14,03 14,09 13,90 13,95 -0,42% 1,41% 6.540.913
17/04/1997 13,97 14,17 13,86 14,01 +0,14% 2,26% 14.119.595
16/04/1997 13,50 14,21 13,42 13,99 +3,66% 5,86% 16.933.775
15/04/1997 13,86 13,86 13,36 13,50 -0,58% 3,57% 17.699.611
14/04/1997 13,20 13,60 13,12 13,58 +3,00% 3,59% 7.631.171
11/04/1997 13,34 13,38 13,14 13,18 -2,20% 1,78% 7.461.055
10/04/1997 13,30 13,62 13,26 13,48 +1,34% 2,67% 13.122.300